v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2023   188,951,643      
Beginning balance at Dec. 31, 2023 $ 158,071 $ 189 $ 1,037,015 $ (880,258) $ 1,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (70,578)     (70,531) (47)
Issuance of common stock upon vesting of restricted stock units (in shares)   2,357,723      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Forfeitures (in shares)   (2,799)      
Shares withheld related to net restricted stock settlement (in shares)   (69,820)      
Shares withheld related to net restricted stock settlement (350)   (350)    
Equity-based compensation 37,638   37,638    
Repurchase of noncontrolling interest attributable to subsidiary 15       15
Ending balance (in shares) at Jun. 30, 2024   191,236,747      
Ending balance at Jun. 30, 2024 124,798 $ 191 1,074,303 (950,789) 1,093
Beginning balance (in shares) at Mar. 31, 2024   191,156,569      
Beginning balance at Mar. 31, 2024 132,017 $ 191 1,057,519 (926,779) 1,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (24,003)     (24,010) 7
Issuance of common stock upon vesting of restricted stock units (in shares)   80,178      
Equity-based compensation 16,784   16,784    
Ending balance (in shares) at Jun. 30, 2024   191,236,747      
Ending balance at Jun. 30, 2024 $ 124,798 $ 191 1,074,303 (950,789) 1,093
Beginning balance (in shares) at Dec. 31, 2024 191,778,639 191,778,639      
Beginning balance at Dec. 31, 2024 $ 100,955 $ 192 1,107,952 (1,008,293) 1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options exercised (in shares) 24,472        
Ending balance (in shares) at Mar. 31, 2025   197,667,653      
Ending balance at Mar. 31, 2025 $ 108,995 $ 198 1,125,340 (1,017,407) 864
Beginning balance (in shares) at Dec. 31, 2024 191,778,639 191,778,639      
Beginning balance at Dec. 31, 2024 $ 100,955 $ 192 1,107,952 (1,008,293) 1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 6,299     6,553 (254)
Issuance of common stock upon vesting of restricted stock units (in shares)   6,056,296      
Forfeitures (in shares)   (277)      
Equity-based compensation 32,740 $ 6 32,734    
Stock options exercised (in shares)   123,579      
Stock options exercised 1,823   1,823    
Sale of consolidated subsidiary $ (850)       (850)
Ending balance (in shares) at Jun. 30, 2025 197,958,237 197,958,237      
Ending balance at Jun. 30, 2025 $ 140,967 $ 198 1,142,509 (1,001,740) 0
Beginning balance (in shares) at Mar. 31, 2025   197,667,653      
Beginning balance at Mar. 31, 2025 108,995 $ 198 1,125,340 (1,017,407) 864
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 15,653     15,667 (14)
Issuance of common stock upon vesting of restricted stock units (in shares)   191,477      
Equity-based compensation $ 15,553 $ 0 15,553    
Stock options exercised (in shares) 99,107 99,107      
Stock options exercised $ 1,616   1,616    
Sale of consolidated subsidiary $ (850)       (850)
Ending balance (in shares) at Jun. 30, 2025 197,958,237 197,958,237      
Ending balance at Jun. 30, 2025 $ 140,967 $ 198 $ 1,142,509 $ (1,001,740) $ 0